Search research articles
Contact Us
Filters
Showing results (11-20 of 323) with videos related to
Page
of 33
Sort By:
European Urology
|
November 17, 2007
Radical prostatectomy in advanced-stage and -grade disease: cure, cytoreduction, or cosmetics?
Arnulf Stenzl, Axel S Merseburger
Aktuelle Urologie
|
October 28, 2020
[TITAN study: evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)]
Axel S Merseburger, Henrik Suttmann
Current Opinion in Urology
|
December 1, 2016
Editorial comment
Yair Lotan, Axel S Merseburger
Aktuelle Urologie
|
August 23, 2023
Axel S Merseburger, Hubert Kübler
European Urology Focus
|
July 21, 2017
Clinical Case Discussion: Isolated Lung Metastases After Radical Nephrectomy for Clear Cell Carcinoma: The Case for Surgery
Axel S Merseburger, Emanuel Palade
Expert Review of Anticancer Therapy
|
May 25, 2022
Advanced delivery of leuprorelin acetate for the treatment of prostatic cancer
Axel S Merseburger, Marie Christine Roesch
Current Opinion in Urology
|
September 1, 2007
The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery
Axel S Merseburger, Markus A Kuczyk
World Journal of Urology
|
July 23, 2011
Urothelial carcinoma
Axel S Merseburger, Shahrokh F Shariat
World Journal of Urology
|
February 13, 2008
Changing concepts in the surgery of renal cell carcinoma
Axel S Merseburger, Markus A Kuczyk
World Journal of Urology
|
February 16, 2021
Advanced prostate cancer
Marie C Hupe, Axel S Merseburger
Page
of 33
Search research articles
Search
Showing results (11-20 of 323) with videos related to
Sort By:
Page
of 33
European Urology
|
November 17, 2007
Radical prostatectomy in advanced-stage and -grade disease: cure, cytoreduction, or cosmetics?
Arnulf Stenzl, Axel S Merseburger
Aktuelle Urologie
|
October 28, 2020
[TITAN study: evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)]
Axel S Merseburger, Henrik Suttmann
Current Opinion in Urology
|
December 1, 2016
Editorial comment
Yair Lotan, Axel S Merseburger
Aktuelle Urologie
|
August 23, 2023
Axel S Merseburger, Hubert Kübler
European Urology Focus
|
July 21, 2017
Clinical Case Discussion: Isolated Lung Metastases After Radical Nephrectomy for Clear Cell Carcinoma: The Case for Surgery
Axel S Merseburger, Emanuel Palade
Expert Review of Anticancer Therapy
|
May 25, 2022
Advanced delivery of leuprorelin acetate for the treatment of prostatic cancer
Axel S Merseburger, Marie Christine Roesch
Current Opinion in Urology
|
September 1, 2007
The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery
Axel S Merseburger, Markus A Kuczyk
World Journal of Urology
|
July 23, 2011
Urothelial carcinoma
Axel S Merseburger, Shahrokh F Shariat
World Journal of Urology
|
February 13, 2008
Changing concepts in the surgery of renal cell carcinoma
Axel S Merseburger, Markus A Kuczyk
World Journal of Urology
|
February 16, 2021
Advanced prostate cancer
Marie C Hupe, Axel S Merseburger
Page
of 33